MME and portal hypertension: Sansoè et al. showed that neutral endopeptidase inhibition by candoxatrilat reduced portal pressure and intrahepatic vascular resistance in cirrhotic rats, suggesting the beneficial effect by elevating NPs to ameliorate portal hypertension [12].